Akèy › Skizofreni
Etid klinik pou Skizofreni ap rekrite nan Etazini
105 etid pou Skizofreni ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Atlanta, GA22 etid
- Chicago, IL20 etid
- Little Rock, AR19 etid
- Hollywood, FL15 etid
- Boston, MA14 etid
- Austin, TX13 etid
- Houston, TX13 etid
- Hialeah, FL13 etid
- New York City, NY13 etid
- San Diego, CA13 etid
- Garden Grove, CA12 etid
- Germantown, MD11 etid
- Camden, NJ10 etid
- Miami, FL10 etid
- Richardson, TX9 etid
- Grand Prairie, TX8 etid
- Philadelphia, PA8 etid
- Anaheim, CA8 etid
- Inglewood, CA8 etid
- Johns Creek, GA8 etid
- El Cajon, CA8 etid
- Cambridge, MA8 etid
- Dallas, TX8 etid
- Los Angeles, CA8 etid
- Cincinnati, OH8 etid
- West Palm Beach, FL7 etid
- Las Vegas, NV7 etid
- Orange, CA7 etid
- Springdale, AR7 etid
- St. Louis, MO7 etid
- Staten Island, NY7 etid
- Pittsburgh, PA7 etid
- Riverside, CA6 etid
- Akron, OH6 etid
- Torrance, CA6 etid
- Downey, CA6 etid
- The Bronx, NY6 etid
- Orlando, FL6 etid
- Oceanside, CA6 etid
- Queens, NY6 etid
Pa eta
- Alabama4 etid
- Arizona4 etid
- Arkansas21 etid
- Colorado3 etid
- Connecticut9 etid
- Florid26 etid
- Georgia29 etid
- Illinois25 etid
- Kalifòni44 etid
- Maryland17 etid
- Massachusetts22 etid
- Michigan5 etid
- Minnesota4 etid
- Mississippi3 etid
- Missouri10 etid
- Nebraska6 etid
- Nevada7 etid
- New Jersey13 etid
- New York23 etid
- North Carolina3 etid
- Ohio18 etid
- Oklahoma4 etid
- Pennsylvania15 etid
- Tennessee6 etid
- Texas34 etid
- Virginia6 etid
- Washington8 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT06835556Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 28, 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227818NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07105098Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Sep 23, 2026 · NCT07680946State Representation in Early Psychosis 2
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 15 a 45 · Tout sèks · Mizajou Sep 22, 2026 · NCT07834203A Study of Brenipatide in Adult Participants With Schizophrenia
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 17, 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Ap rekrite
Laj 22 a 65 · Tout sèks · Mizajou Sep 16, 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Ap rekriteFaz 3
Laj 13 a 17 · Tout sèks · Mizajou Sep 4, 2026 · NCT07288567Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Ap rekriteFaz 1Volontè an sante akeyi
Laj 21 a 60 · Tout sèks · Mizajou Sep 2, 2026 · NCT06058702A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Ap rekriteVolontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Aug 31, 2026 · NCT07680114Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Aug 31, 2026 · NCT06911723Cerebellar Modulation of Cognition in Psychosis
Ap rekrite
Laj 18 a 55 · Tout sèks · Mizajou Aug 20, 2026 · NCT06107764Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07379827Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.